Mds pharma services

MDS Pharma Services: A Global Leader in Contract Research Organization

MDS Pharma Services is a leading global contract research organization (CRO) that provides a full range of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With facilities in more than 23 countries, MDS Pharma Services applies advanced scientific and technological expertise to each stage of the drug discovery and development process.

Discovery

The first stage of drug discovery involves identifying new compounds that have potential therapeutic benefits. MDS Pharma Services has a team of experienced scientists who use state-of-the-art technologies to identify new compounds with potential therapeutic benefits. They also conduct extensive research on existing drugs to determine their efficacy, safety, and side effects.

Preclinical

Once promising compounds are identified, they move on to preclinical testing. This stage involves testing the compound's safety profile in animals before it can be tested in humans. MDS Pharma Services has extensive experience in conducting preclinical studies using various animal models.

Early Clinical Research (Phases I-IIa)

After successful completion of preclinical studies, the next step is early clinical research involving human subjects. This phase includes Phase I studies which evaluate safety profiles and pharmacokinetics (how drugs are absorbed, distributed, metabolized, and excreted by the body) as well as Phase IIa studies which evaluate efficacy at different doses or schedules.

Bioanalytical

Bioanalytical services involve measuring drug concentrations in biological samples such as blood or urine from clinical trial participants. These measurements help determine how much of a drug is present in a patient's body at any given time during treatment. MDS Pharma Services has state-of-the-art bioanalytical laboratories equipped with advanced technologies for accurate measurement of drugs' concentrations.

Global Clinical Research (Phases IIb-IV)

The next phase after early clinical research is global clinical research involving larger groups of patients across multiple sites worldwide. This phase includes Phase IIb-IV trials which evaluate efficacy under controlled conditions while monitoring adverse events associated with long-term use.

Central Lab

Central lab services involve analyzing biological samples collected from multiple sites during global clinical trials for consistency across all study sites worldwide. MDS Pharma Services has central labs located globally equipped with advanced technologies for accurate analysis ensuring data integrity throughout all phases of clinical trials.

Conclusion:

In conclusion, MDS Pharma Services offers comprehensive solutions for every stage involved in drug discovery and development processes ranging from initial compound identification through regulatory approval stages including post-marketing surveillance activities globally across multiple therapeutic areas such as oncology/hematology; cardiovascular/metabolic diseases; infectious diseases/vaccines; neuroscience/pain management; respiratory/allergy/immunology among others.

With its vast experience spanning over several decades coupled with cutting-edge technology platforms available at its disposal makes it an ideal partner for pharmaceutical/biotech companies looking forward to outsourcing their R&D activities while maintaining high-quality standards throughout all phases involved.

Therefore if you're looking forward to partnering with an experienced CRO that can provide end-to-end solutions tailored specifically according to your requirements then look no further than MDS pharma services!